Literature DB >> 19567759

Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery.

José R Maldonado1, Ashley Wysong, Pieter J A van der Starre, Thaddeus Block, Craig Miller, Bruce A Reitz.   

Abstract

BACKGROUND: Delirium is a neurobehavioral syndrome caused by the transient disruption of normal neuronal activity secondary to systemic disturbances.
OBJECTIVE: The authors investigated the effects of postoperative sedation on the development of delirium in patients undergoing cardiac-valve procedures.
METHODS: Patients underwent elective cardiac surgery with a standardized intraoperative anesthesia protocol, followed by random assignment to one of three postoperative sedation protocols: dexmedetomidine, propofol, or midazolam.
RESULTS: The incidence of delirium for patients receiving dexmedetomidine was 3%, for those receiving propofol was 50%, and for patients receiving midazolam, 50%. Patients who developed postoperative delirium experienced significantly longer intensive-care stays and longer total hospitalization.
CONCLUSION: The findings of this open-label, randomized clinical investigation suggest that postoperative sedation with dexmedetomidine was associated with significantly lower rates of postoperative delirium and lower care costs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19567759     DOI: 10.1176/appi.psy.50.3.206

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  108 in total

1.  Postoperative delirium: a 76-year-old woman with delirium following surgery.

Authors:  Edward R Marcantonio
Journal:  JAMA       Date:  2012-07-04       Impact factor: 56.272

2.  The assessment and management of agitation and delirium in the general hospital.

Authors:  Theodore A Stern; Christopher M Celano; Anne F Gross; Jeff C Huffman; Oliver Freudenreich; Nicholas Kontos; Shamim H Nejad; Jennifer Repper-Delisi; B Taylor Thompson
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

3.  Current approaches to the recognition and treatment of alcohol withdrawal and delirium tremens: "old wine in new bottles" or "new wine in old bottles".

Authors:  Theodore A Stern; Anne F Gross; Thomas W Stern; Shamim H Nejad; Jose R Maldonado
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

Review 4.  Hypothesis: Fever control, a niche for alpha-2 agonists in the setting of septic shock and severe acute respiratory distress syndrome?

Authors:  F Petitjeans; S Leroy; C Pichot; A Geloen; M Ghignone; L Quintin
Journal:  Temperature (Austin)       Date:  2018-05-22

5.  Benzodiazepine-associated delirium in critically ill adults.

Authors:  Irene J Zaal; John W Devlin; Marijn Hazelbag; Peter M C Klein Klouwenberg; Arendina W van der Kooi; David S Y Ong; Olaf L Cremer; Rolf H Groenwold; Arjen J C Slooter
Journal:  Intensive Care Med       Date:  2015-09-24       Impact factor: 17.440

Review 6.  Dexmedetomidine: a review of its use for sedation in mechanically ventilated patients in an intensive care setting and for procedural sedation.

Authors:  Sheridan M Hoy; Gillian M Keating
Journal:  Drugs       Date:  2011-07-30       Impact factor: 9.546

7.  Factors associated with post-surgical delirium in patients undergoing open heart surgery.

Authors:  Yadollah Jannati; Masoumeh Bagheri-Nesami; Maryam Sohrabi; Jamshid Yazdani-Cherati; Shahrzad Mazdarani
Journal:  Oman Med J       Date:  2014-09

Review 8.  Randomized ICU trials do not demonstrate an association between interventions that reduce delirium duration and short-term mortality: a systematic review and meta-analysis.

Authors:  Nada S Al-Qadheeb; Ethan M Balk; Gilles L Fraser; Yoanna Skrobik; Richard R Riker; John P Kress; Shawn Whitehead; John W Devlin
Journal:  Crit Care Med       Date:  2014-06       Impact factor: 7.598

Review 9.  Perioperative cognitive protection.

Authors:  C Brown; S Deiner
Journal:  Br J Anaesth       Date:  2016-12       Impact factor: 9.166

Review 10.  Frailty, Aging, and Cardiovascular Surgery.

Authors:  Antonio Graham; Charles H Brown
Journal:  Anesth Analg       Date:  2017-04       Impact factor: 5.108

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.